サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1464658

診断用放射性同位元素市場：ラジオアイソトープ別、用途別、画像診断法別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

Diagnostic Radioisotopes Market, By Radioisotope, By Application, By Imaging Modality, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 301 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
診断用放射性同位元素市場：ラジオアイソトープ別、用途別、画像診断法別、エンドユーザー別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年04月01日
発行: AnalystView Market Insights
ページ情報: 英文 301 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

診断用放射性同位元素市場規模は2023年に58億2,021万米ドルとなり、2024年から2032年にかけてCAGR 9.81％で拡大

診断用放射性同位元素市場- 市場力学

慢性疾患の有病率の上昇が市場成長を促進すると予測される

がん、心臓病、神経疾患などの慢性疾患では、疾患の進行のモニタリング、治療効果の評価、再発の特定などのために、頻繁な画像診断が必要となることが多いです。診断用放射性同位元素は、陽電子放出断層撮影法（PET）、単光子放出コンピュータ断層撮影法（SPECT）、ガンマカメラ撮影法などの様々な画像診断技術に不可欠であり、慢性疾患の正確な診断と病期分類を容易にしています。米国国立健康統計センターによると、慢性疾患とは3ヶ月以上続くものを指します。約4,000万人のアメリカ人が、1つ以上の慢性疾患により日常生活に制限を受けています。ハイブリッド画像技術の採用が増加していることは、同市場に成長機会をもたらしています。しかし、生産コストとインフラコストが高いことが市場成長の妨げになる可能性があります。

診断用放射性同位元素市場-主要インサイト

当社のリサーチアナリストが共有した分析によると、世界市場は予測期間（2024-2032年）に約9.81％のCAGRで年間成長すると推定されています。

放射性同位元素別では、テクネチウム-99mは2023年に最大の市場シェアを示すと予測されました。

用途別では、2023年にオンコロジーが主要なタイプでした。

地域別では、北米が2023年に収益を上げる主要市場です。

診断用放射性同位元素市場-セグメンテーション分析：

診断用放射性同位元素の世界市場は、ラジオアイソトープ、用途、画像診断法、エンドユーザー、地域に基づいてセグメント化されます。

市場は放射性同位元素によって5つに区分される：テクネチウム-99m、タリウム-201、ガリウム-67、ヨウ素-123、FDG、ルビジウム-82、その他。テクネチウム-99mが市場で最大のシェアを占めています。テクネチウム-99m（Tc-99m）は、核医学において画像診断に高度に利用されている放射性同位元素です。

市場は用途によって2つに区分される：腫瘍学、循環器学、その他です。腫瘍学が市場で最大のシェアを占めています。診断用放射性同位元素は、腫瘍の検出や特性評価、病勢進行の評価、治療効果の評価など、腫瘍学で利用されるさまざまな画像診断技術において極めて重要です。

市場はイメージングモダリティによって3つのカテゴリーに区分される：SPECT、PET、ベータ放射体です。それぞれの画像診断法は、異なる放射性同位元素を使用して体内の生物学的プロセスや構造を観察し、がんなどのさまざまな疾患の診断、病期分類、治療計画、モニタリングに役立ちます。

市場はエンドユーザーによって4つのカテゴリーに区分される：病院、専門クリニック、診断センター、学術・調査機関、その他の施設です。各エンドユーザーグループは、放射性同位元素を利用した画像診断サービスに対する独自のニーズと需要を持っています。

診断用放射性同位元素市場-地理的洞察

この市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東およびアフリカに地理的に広がっています。これらの地域は、事業活動に関与する国に基づいてさらに分割されます。市場の成長は、主に核医学への投資の増加により、北米が牽引すると予想されます。鼓膜切開用製品市場は主に耳の感染症治療と関連する耳鼻咽喉科処置に重点を置いているのに対し、核医学は放射性同位元素を用いた医療用画像診断と診断が中心です。米国では年間2,000万件以上の核医学治療が行われているが、欧州では約1,000万件で、そのうち200万件が治療目的です。今後は、主に画像診断モダリティの進歩により、欧州が市場成長の原動力になると予測されます。

診断用放射性同位元素市場-競合情勢：

診断用放射性同位元素市場は激しい競合が特徴で、各社は高品質のラジオアイソトープを安定的に供給しようと努力しています。各社はまた、効率的なイメージングソリューションの提供、安全性と規制ガイドラインの遵守、医療従事者と患者の進化するニーズに対応するためのイノベーションの育成に注力しています。さらに、この市場での競合は、放射性医薬品会社が提供する放射性同位元素製品の品質、信頼性、多様性を中心に展開されています。また、生産効率の向上、コスト削減、安全性と規制基準の遵守を確実にするために、技術の進歩も追求されています。

目次

第1章 診断用放射性同位元素市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 診断用放射性同位元素の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 診断用放射性同位元素産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 診断用放射性同位元素市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 診断用放射性同位元素市場情勢

  • 診断用放射性同位元素市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 診断用放射性同位元素市場-ラジオアイソトープ別

  • 概要
    • 放射性同位元素別セグメントシェア分析
    • テクネチウム99m
    • タリウム201
    • ガリウム67
    • ヨウ素123
    • FDG
    • ルビジウム82
    • その他

第8章 診断用放射性同位元素市場- 用途別

  • 概要
    • 用途別セグメントシェア分析
    • 腫瘍学
    • 心臓病学
    • その他

第9章 診断用放射性同位元素市場- 画像診断法別

  • 概要
    • 画像診断法別のセグメントシェア分析
    • SPECT
    • PET
    • ベータ放射体

第10章 診断用放射性同位元素市場- エンドユーザー別

  • 概要
    • エンドユーザー別セグメントシェア分析
    • 病院
    • 専門クリニック
    • 診断センター
    • 学術調査機関
    • その他

第11章 診断用放射性同位元素市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析- 診断用放射性同位元素業界

  • 競合ダッシュボード
  • 企業プロファイル
    • GE Healthcare
    • Siemens Healthineers
    • Koninklijke Philips NV
    • Cardinal Health
    • Lantheus Holdings, Inc.
    • Bayer AG
    • Bracco
    • Eckert &Ziegler
    • Nordion（Canada）Inc.
    • NTP Radioisotopes
    • Curium, Jubilant Life Sciences Ltd
    • Isotopia Molecular Imaging Ltd.
    • Mallinckrodt Nuclear Medicine LLC
    • Jubilant DraxImage Inc.
    • Sumitomo Heavy Industries, Ltd.
    • Telix Pharmaceuticals Limited
    • Others

第13章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Diagnostic Radioisotopes Market: Radioisotope Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Radioisotope
  • TABLE Global Diagnostic Radioisotopes Market, by Radioisotope 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Diagnostic Radioisotopes Market, by Application 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: Imaging Modality Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Imaging Modality
  • TABLE Global Diagnostic Radioisotopes Market, by Imaging Modality 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: End-User Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by End-User
  • TABLE Global Diagnostic Radioisotopes Market, by End-User 2019-2032 (USD Million)
  • TABLE Diagnostic Radioisotopes Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Diagnostic Radioisotopes Market, by Region 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE North America Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Europe Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Asia Pacific Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Latin America Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Radioisotope, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by Imaging Modality, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Diagnostic Radioisotopes Market, by End-User, 2019-2032 (USD Million)
目次
Product Code: ANV2460

REPORT HIGHLIGHT

Diagnostic Radioisotopes Market size was valued at USD 5,820.21 Million in 2023, expanding at a CAGR of 9.81% from 2024 to 2032.

Diagnostic radioisotopes are radioactive isotopes that are employed in medical imaging for the purpose of diagnosing various medical conditions and diseases. These particular radioisotopes emit gamma rays, which can be detected by specialized imaging equipment like gamma cameras or PET scanners. The administration of these radioisotopes to patients is typically done through oral ingestion, intravenous injection, or inhalation, depending on the specific imaging procedure and the organ or tissue under examination. Despite their radioactive nature, the doses utilized in diagnostic imaging are extremely small and are considered safe for patients. In fact, the advantages of diagnostic imaging with radioisotopes often outweigh the potential risks associated with radiation exposure.

Diagnostic Radioisotopes Market- Market Dynamics

Rising Prevalence of Chronic Diseases is anticipated to propel the market growth

Chronic illnesses like cancer, heart diseases, and neurological disorders often necessitate frequent diagnostic imaging for monitoring disease progression, evaluating treatment effectiveness, and identifying recurrence. Diagnostic radioisotopes are essential in various imaging techniques such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and gamma camera imaging, facilitating precise diagnosis and staging of chronic illnesses. According to the U.S. National Center for Health Statistics, a chronic disease is one that lasts for three months or more. Approximately 40 million Americans have limitations in their daily activities due to one or more chronic health conditions. The increasing adoption of hybrid imaging technologies presents a growth opportunity for the market. However, the high cost of production and infrastructure may hinder market growth.

Diagnostic Radioisotopes Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 9.81% over the forecast period (2024-2032)

Based on Radioisotope segmentation, Technetium-99m was predicted to show maximum market share in the year 2023

Based on application segmentation, Oncology was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Diagnostic Radioisotopes Market- Segmentation Analysis:

The Global Diagnostic Radioisotopes Market is segmented on the basis of Radioisotope, Application, Imaging Modality, End-user and Region.

The market is segmented into five divisions according to Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others. Technetium-99m holds the largest share in the market. Technetium-99m (Tc-99m) is a highly utilized radioisotope in nuclear medicine for diagnostic imaging.

The market is segmented into two categories according to application: Oncology, Cardiology, and Other. Oncology holds the largest share in the market. Diagnostic radioisotopes are crucial in different imaging techniques utilized in oncology, assisting in tumor detection and characterization, disease progression assessment, and treatment response evaluation.

The market is segmented into three categories according to Imaging Modality: SPECT, PET, and Beta Emitters. Each imaging modality uses distinct radioisotopes to observe biological processes and structures in the body, aiding in the diagnosis, staging, treatment planning, and monitoring of different diseases, such as cancer.

The market is segmented into four categories according to End-user: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Other establishments. Each end-user group has unique needs and demands for diagnostic imaging services that make use of radioisotopes.

Diagnostic Radioisotopes Market- Geographical Insights

This market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be driven by North America, primarily due to increasing investments in nuclear medicine. The Tympanostomy Products market mainly focuses on the treatment of ear infections and related otolaryngology procedures, while nuclear medicine is centered around medical imaging and diagnosis using radioisotopes. In the United States, there are over 20 million nuclear medicine procedures conducted annually, while in Europe, the number is around 10 million, with 2 million of them being therapeutic procedures. Looking ahead, Europe is projected to be the driving force behind the market's growth, mainly due to advancements in diagnostic imaging modalities.

Diagnostic Radioisotopes Market- Competitive Landscape:

The Diagnostic Radioisotopes Market is characterized by intense competition, with companies striving to ensure a steady and dependable supply of high-quality radioisotopes. They also focus on providing efficient imaging solutions, adhering to safety and regulatory guidelines, and fostering innovation to meet the evolving needs of healthcare professionals and patients. Additionally, competition in this market revolves around the quality, reliability, and variety of radioisotope products offered by radio pharmaceutical companies. Technological advancements are also pursued to improve production efficiency, lower costs, and ensure compliance with safety and regulatory standards.

Recent Developments:

Siemens Healthineers has announced its decision to close down its Fast Track Diagnostics unit, a division within the Diagnostics business that offers polymerase chain reaction (PCR) testing products. This particular portfolio is primarily sold in Europe. The demand for these products has significantly declined since the peak of the COVID-19 pandemic.

Another advancement in medical imaging is positron emission tomography (PET), a highly accurate and advanced technique that utilizes isotopes generated in a cyclotron. By introducing a positron-emitting radionuclide, typically through injection, it accumulates in the specific tissue being targeted.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GE Healthcare

Siemens Healthineers

Koninklijke Philips N.V.

Cardinal Health

Lantheus Holdings, Inc.

Bayer AG

Bracco

Eckert & Ziegler

Nordion (Canada) Inc.

NTP Radioisotopes

Curium, Jubilant Life Sciences Ltd

Isotopia Molecular Imaging Ltd.

Mallinckrodt Nuclear Medicine LLC

Jubilant DraxImage Inc.

Sumitomo Heavy Industries, Ltd.

Telix Pharmaceuticals Limited

Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY RADIOISOTOPE- MARKET ANALYSIS, 2019 - 2032

  • Technetium-99m
  • Thallium-201
  • Gallium-67
  • Iodine-123
  • FDG
  • Rubidium-82
  • Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Cardiology
  • Other

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY IMAGING MODALITY- MARKET ANALYSIS, 2019 - 2032

  • SPECT
  • PET
  • Beta Emitters

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

GLOBAL DIAGNOSTIC RADIOISOTOPES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Diagnostic Radioisotopes Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Diagnostic Radioisotopes Market Snippet by Radioisotope
    • 2.1.2.Diagnostic Radioisotopes Market Snippet by Application
    • 2.1.3.Diagnostic Radioisotopes Market Snippet by Imaging Modality
    • 2.1.4.Diagnostic Radioisotopes Market Snippet by End-User
    • 2.1.5.Diagnostic Radioisotopes Market Snippet by Country
    • 2.1.6.Diagnostic Radioisotopes Market Snippet by Region
  • 2.2.Competitive Insights

3.Diagnostic Radioisotopes Key Market Trends

  • 3.1.Diagnostic Radioisotopes Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Diagnostic Radioisotopes Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Diagnostic Radioisotopes Market Opportunities
  • 3.4.Diagnostic Radioisotopes Market Future Trends

4.Diagnostic Radioisotopes Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Diagnostic Radioisotopes Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Diagnostic Radioisotopes Market Landscape

  • 6.1.Diagnostic Radioisotopes Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Diagnostic Radioisotopes Market - By Radioisotope

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Radioisotope, 2023 & 2032 (%)
    • 7.1.2.Technetium-99m
    • 7.1.3.Thallium-201
    • 7.1.4.Gallium-67
    • 7.1.5.Iodine-123
    • 7.1.6.FDG
    • 7.1.7.Rubidium-82
    • 7.1.8.Others

8.Diagnostic Radioisotopes Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Oncology
    • 8.1.3.Cardiology
    • 8.1.4.Other

9.Diagnostic Radioisotopes Market - By Imaging Modality

  • 9.1.Overview
    • 9.1.1.Segment Share Analysis, By Imaging Modality, 2023 & 2032 (%)
    • 9.1.2.SPECT
    • 9.1.3.PET
    • 9.1.4.Beta Emitters

10.Diagnostic Radioisotopes Market - By End-User

  • 10.1.Overview
    • 10.1.1.Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2.Hospitals
    • 10.1.3.Specialty Clinics
    • 10.1.4.Diagnostic Centers
    • 10.1.5.Academic & Research Institutes
    • 10.1.6.Others

11.Diagnostic Radioisotopes Market- By Geography

  • 11.1.Introduction
    • 11.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2.North America
    • 11.2.1.Overview
    • 11.2.2.Diagnostic Radioisotopes Key Manufacturers in North America
    • 11.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4.North America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6.North America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.2.7.North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8.U.S.
      • 11.2.8.1.Overview
      • 11.2.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3.U.S. Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.2.8.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5.U.S. Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.2.8.6.U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9.Canada
      • 11.2.9.1.Overview
      • 11.2.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3.Canada Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.2.9.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5.Canada Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.2.9.6.Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3.Europe
    • 11.3.1.Overview
    • 11.3.2.Diagnostic Radioisotopes Key Manufacturers in Europe
    • 11.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4.Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6.Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.3.7.Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8.Germany
      • 11.3.8.1.Overview
      • 11.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3.Germany Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.8.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5.Germany Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.8.6.Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9.Italy
      • 11.3.9.1.Overview
      • 11.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3.Italy Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.9.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5.Italy Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.9.6.Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10.United Kingdom
      • 11.3.10.1.Overview
      • 11.3.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3.United Kingdom Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.10.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5.United Kingdom Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.10.6.United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11.France
      • 11.3.11.1.Overview
      • 11.3.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3.France Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.11.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5.France Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.11.6.France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12.Russia
      • 11.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2.Russia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.12.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.4.Russia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.12.5.Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13.Netherlands
      • 11.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2.Netherlands Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.13.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4.Netherlands Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.13.5.Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14.Sweden
      • 11.3.14.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2.Sweden Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.14.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4.Sweden Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.14.5.Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15.Poland
      • 11.3.15.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2.Poland Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.15.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4.Poland Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.15.5.Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16.Rest of Europe
      • 11.3.16.1.Overview
      • 11.3.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3.Rest of the Europe Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.3.16.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.5.Rest of the Europe Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.3.16.6.Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4.Asia Pacific (APAC)
    • 11.4.1.Overview
    • 11.4.2.Diagnostic Radioisotopes Key Manufacturers in Asia Pacific
    • 11.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4.Asia Pacific Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6.Asia Pacific Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.4.7.Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8.India
      • 11.4.8.1.Overview
      • 11.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3.India Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.8.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5.India Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.8.6.India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9.China
      • 11.4.9.1.Overview
      • 11.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3.China Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.9.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5.China Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.9.6.China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10.Japan
      • 11.4.10.1.Overview
      • 11.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3.Japan Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.10.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5.Japan Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.10.6.Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11.South Korea
      • 11.4.11.1.Overview
      • 11.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3.South Korea Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.11.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5.South Korea Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.11.6.South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12.Australia
      • 11.4.12.1.Overview
      • 11.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3.Australia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.12.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5.Australia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.12.6.Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13.Thailand
      • 11.4.13.1.Overview
      • 11.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3.Thailand Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.13.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5.Thailand Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.13.6.Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14.Indonesia
      • 11.4.14.1.Overview
      • 11.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3.Indonesia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.14.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5.Indonesia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.14.6.Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15.Philippines
      • 11.4.15.1.Overview
      • 11.4.15.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3.Philippines Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.15.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5.Philippines Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.15.6.Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16.Rest of APAC
      • 11.4.16.1.Overview
      • 11.4.16.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3.Rest of APAC Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.4.16.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5.Rest of APAC Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.4.16.6.Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5.Latin America
    • 11.5.1.Overview
    • 11.5.2.Diagnostic Radioisotopes Key Manufacturers in Latin America
    • 11.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4.Latin America Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6.Latin America Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.5.7.Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8.Brazil
      • 11.5.8.1.Overview
      • 11.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3.Brazil Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.8.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5.Brazil Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.8.6.Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9.Mexico
      • 11.5.9.1.Overview
      • 11.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3.Mexico Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.9.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5.Mexico Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.9.6.Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10.Argentina
      • 11.5.10.1.Overview
      • 11.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3.Argentina Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.10.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5.Argentina Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.10.6.Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11.Colombia
      • 11.5.11.1.Overview
      • 11.5.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3.Colombia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.11.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5.Colombia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.11.6.Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12.Rest of LATAM
      • 11.5.12.1.Overview
      • 11.5.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3.Rest of LATAM Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.5.12.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5.Rest of LATAM Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.5.12.6.Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6.Middle East and Africa
    • 11.6.1.Overview
    • 11.6.2.Diagnostic Radioisotopes Key Manufacturers in Middle East and Africa
    • 11.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4.Middle East and Africa Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
    • 11.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6.Middle East and Africa Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
    • 11.6.7.Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8.Saudi Arabia
      • 11.6.8.1.Overview
      • 11.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3.Saudi Arabia Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.8.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5.Saudi Arabia Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.8.6.Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9.United Arab Emirates
      • 11.6.9.1.Overview
      • 11.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3.United Arab Emirates Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.9.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5.United Arab Emirates Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.9.6.United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10.Israel
      • 11.6.10.1.Overview
      • 11.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3.Israel Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.10.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5.Israel Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.10.6.Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11.Turkey
      • 11.6.11.1.Overview
      • 11.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3.Turkey Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.11.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5.Turkey Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.11.6.Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12.Algeria
      • 11.6.12.1.Overview
      • 11.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3.Algeria Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.12.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5.Algeria Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.12.6.Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13.Egypt
      • 11.6.13.1.Overview
      • 11.6.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3.Egypt Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.13.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5.Egypt Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.13.6.Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14.Rest of MEA
      • 11.6.14.1.Overview
      • 11.6.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3.Rest of MEA Market Size and Forecast, By Radioisotope, 2019 - 2032 (US$ Million)
      • 11.6.14.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5.Rest of MEA Market Size and Forecast, By Imaging Modality, 2019 - 2032 (US$ Million)
      • 11.6.14.6.Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12.Key Vendor Analysis- Diagnostic Radioisotopes Industry

  • 12.1.Competitive Dashboard
  • 12.2.Company Profiles
    • 12.2.1.GE Healthcare
    • 12.2.2.Siemens Healthineers
    • 12.2.3.Koninklijke Philips N.V.
    • 12.2.4.Cardinal Health
    • 12.2.5. Lantheus Holdings, Inc.
    • 12.2.6.Bayer AG
    • 12.2.7.Bracco
    • 12.2.8. Eckert & Ziegler
    • 12.2.9.Nordion (Canada) Inc.
    • 12.2.10.NTP Radioisotopes
    • 12.2.11.Curium, Jubilant Life Sciences Ltd
    • 12.2.12.Isotopia Molecular Imaging Ltd.
    • 12.2.13.Mallinckrodt Nuclear Medicine LLC
    • 12.2.14.Jubilant DraxImage Inc.
    • 12.2.15.Sumitomo Heavy Industries, Ltd.
    • 12.2.16.Telix Pharmaceuticals Limited
    • 12.2.17.Others

13.360 Degree Analyst View

14.Appendix

  • 14.1.Research Methodology
  • 14.2.References
  • 14.3.Abbreviations
  • 14.4.Disclaimer
  • 14.5.Contact Us